Fibroblast Growth Factor 23 and Inflammation in CKD

Levels of fibroblast growth factor 23 (FGF23) and inflammatory markers are commonly elevated in CKD, and each is associated with adverse clinical outcomes. This study tested the hypothesis that FGF23 is independently associated with inflammation in CKD. The association between levels of FGF23 and th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical journal of the American Society of Nephrology 2012-07, Vol.7 (7), p.1155-1162
Hauptverfasser: Munoz Mendoza, Jair, Isakova, Tamara, Ricardo, Ana C, Xie, Huiliang, Navaneethan, Sankar D, Anderson, Amanda H, Bazzano, Lydia A, Xie, Dawei, Kretzler, Matthias, Nessel, Lisa, Hamm, L Lee, Negrea, Lavinia, Leonard, Mary B, Raj, Dominic, Wolf, Myles
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Levels of fibroblast growth factor 23 (FGF23) and inflammatory markers are commonly elevated in CKD, and each is associated with adverse clinical outcomes. This study tested the hypothesis that FGF23 is independently associated with inflammation in CKD. The association between levels of FGF23 and the inflammatory markers IL-6, C-reactive protein (CRP), TNF-α, and fibrinogen was assessed in a cross-sectional analysis of 3879 participants enrolled in the Chronic Renal Insufficiency Cohort (CRIC) study between June 2003 and September 2008. FGF23 correlated directly with IL-6 (r=0.4), CRP (r=0.2), TNF-α (r=0.4), and fibrinogen (r=0.3; P
ISSN:1555-9041
1555-905X
DOI:10.2215/CJN.13281211